/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Kevin Ebata

Loxo Oncology at Lilly (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

77

Papers

9.1K

Citations

27

h-index

35

i10-index

Kevin Ebata is an academic researcher from Loxo Oncology at Lilly (United States). The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Vitamin C and Antioxidants Research & Chronic Lymphocytic Leukemia Research. The author has an h-index of 27, co-authored 66 publications.

ORCID: 0000-0001-7166-7513

Research Topics

Lung Cancer Treatments and Mutations Vitamin C and Antioxidants Research Chronic Lymphocytic Leukemia Research Pluripotent Stem Cells Research Colorectal Cancer Treatments and Studies

Papers by this author

works

Bivalent Chromatin Marks Developmental Regulatory Genes in the Mouse Embryonic Germline In Vivo

2013 · Cell Reports · 176 citations

https://doi.org/10.1016/j.celrep.2013.04.032

Michael Sachs Courtney Onodera Kathryn Blaschke Kevin Ebata

The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers

2022 · Nature Communications · 105 citations

https://doi.org/10.1038/s41467-022-28848-x

Ezra Y. Rosen Helen Won Youyun Zheng Emiliano Cocco

Research topics

topics

Lung Cancer Treatments and Mutations

Vitamin C and Antioxidants Research

Chronic Lymphocytic Leukemia Research

Pluripotent Stem Cells Research

Colorectal Cancer Treatments and Studies

Chat about Author

Papers

Chat

Click to start Chat